Bristol, United Kingdom · Founded 2019 · Privately Held (backing)
Developer of live biotherapeutics designed to treat inflammatory conditions in humans and animals. Ferryx is based in Bristol, United Kingdom and was founded in 2019. Its last reported valuation was $3.9 million in Apr 2026. It has raised $960,000.
Last reported valuation
$3.9M
Nov 2026
Priced at
—
Total raised
$960K
Last round
—
Cap table — not yet on record
Ferryx's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
